At the end of this module, the participant should:

• Become familiar with the appropriate use of [18F]FDG PET/CT in patients with gynecological malignancies.
• Understand the rationale of using [18F]FDG PET/CT at various stages during the course of disease in patients with gynecolgical malignancies.
• Recognize the more frequent pattems of metastatic disease in patients with gynecological malignancies as visualized by hybrid imaging with [18F]FDG PET/CT.
• Understand how radioguided sentinel lymph node biopsy is pefformed in patients with cervical cancer, including the possible use of a hybrid tracer with dual signature (optic and radioactive).